Supernus Pharma Balance Sheet - Quarterly (NASDAQ:SUPN)

Add to My Stocks
$46.9 $0.9 (1.96%) SUPN stock closing price Sep 18, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Supernus Pharma, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Supernus Pharma stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Apart from analyzing Supernus Pharma revenue Supernus Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Supernus Pharma balance sheet for 2018 Q2 shows cash on hand of $35.21M. The company has a debt to equity ratio of 0.82.

View and download Supernus Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities139.21M45.58M39.73M32.62M31.22M27.53M23.72M26.02M24.05M25.42M
Raw Materials2.91M1.77M2.99M2.17M2.97M4.3M2.09M2.78M2.93M2.37M
Work In Progress6.14M10M8.87M4.69M8.64M9.39M8.87M8.11M6.23M4.26M
Finished Goods11.62M7.29M4.43M8.07M5M5.46M5.83M6.55M7.2M6.4M
Notes Receivable----------
Other Current Assets14.58M6.58M6.52M5.66M4.74M4.57M2.95M4.2M3.27M5M
Total Current Assets
Property Plant & Equipment15.14M14.76M14.47M13.71M13.29M12.74M12.44M12.14M11.74M11.12M
Accumulated Depreciation10.25M9.76M9.34M9.02M8.72M8.39M8.09M7.82M7.55M7.25M
Net Property Plant & Equipment
Investment & Advances503.31M175.06M133.63M123.12M104.63M89.16M75.41M67.04M67.8M68.79M
Other Non-Current Assets----------
Deferred Charges25.53M26.25M20.84M28.8M42.33M49.19M61.58M59.69M16.38M11.44M
Deposits & Other Assets----------
Total Assets
Notes Payable------11.8M6.77M--
Accounts Payable2.94M3.33M6.84M6.26M7.57M5.05M8.05M2.68M2.24M2.64M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses99.33M114.32M111.58M93.15M72.66M72.01M69.37M66.41M63.12M51.27M
Income Taxes Payable----------
Other Current Liabilities1.66M1.43M4.57M5.54M5.28M4.93M3.31M2.54M--
Total Current Liabilities
Deferred Taxes/Income--1.14M1.22M1.29M1.36M1.5M1.55M1.6M1.65M
Convertible Debt321.92M318.22M--1.47M3.31M4.16M5.77M5.69M5.62M
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities36.45M35.97M32.83M27.63M28.68M29.51M31.4M32.77M4.73M34.54M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus361.97M352.25M294.99M291.84M285.57M279.79M276.12M271.8M270.05M267.57M
Retained Earnings32.59M1.85M-26.82M-40.48M-56.44M-73.81M-84.28M-98.6M-129.63M-139.65M
Treasury Stock----------
Other Liabilities-4.12M-2.29M-0.74M----0.13M---
Shareholders Equity390.49M351.86M267.48M251.66M229.39M206.06M191.75M173.37M141.02M128.13M
Total Liabilities & Shareholders Equity852.8M825.16M424.46M385.47M346.37M322.25M309.56M285.11M218.63M194.47M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Supernus Pharma historical stock prices and the current Supernus Pharma stock price can tell you how the stock price has moved, whereas the Supernus Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Supernus Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for SUPN stock as of 2018 Q2 is $852.8M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Supernus Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for SUPN stock stand at $462.31M.

Supernus Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio